315 related articles for article (PubMed ID: 3981060)
1. Mass spectrometry identification of biliary bile acids in bile from patients with gallstones before and during treatment with chenodeoxycholic acid. An ancillary study of the National Cooperative Gallstone Study.
Stellaard F; Klein PD; Hofmann AF; Lachin JM
J Lab Clin Med; 1985 Apr; 105(4):504-13. PubMed ID: 3981060
[TBL] [Abstract][Full Text] [Related]
2. Increased formation of ursodeoxycholic acid in patients treated with chenodeoxycholic acid.
Salen G; Tint GS; Eliav B; Deering N; Mosbach EH
J Clin Invest; 1974 Feb; 53(2):612-21. PubMed ID: 11344576
[TBL] [Abstract][Full Text] [Related]
3. Chenotherapy for gallstone dissolution. II. Induced changes in bile composition and gallstone response.
Hofmann AF; Thistle JL; Klein PD; Szczepanik PA; Yu PY
JAMA; 1978 Mar; 239(12):1138-44. PubMed ID: 628065
[TBL] [Abstract][Full Text] [Related]
4. Effect of oral chenodeoxycholic acid on bile acid kinetics and biliary lipid composition in women with cholelithiasis.
Danzinger RC; Hofmann AF; Thistle JL; Schoenfield LJ
J Clin Invest; 1973 Nov; 52(11):2809-21. PubMed ID: 4583981
[TBL] [Abstract][Full Text] [Related]
5. Effect of varying doses of chenodeoxycholic acid on bile lipid and biliary bile acid composition in gallstone patients: a dose-response study.
Thistle JL; Hofmann AF; Yu PY; Ott B
Am J Dig Dis; 1977 Jan; 22(1):1-6. PubMed ID: 835542
[TBL] [Abstract][Full Text] [Related]
6. Differing effects of ursodeoxycholic or chenodeoxycholic acid on biliary cholesterol saturation and bile acid metabolism in man. A dose-response study.
Thistle JL; Larusso NF; Hofmann AF; Turcotte J; Carlson GL; Ott BJ
Dig Dis Sci; 1982 Feb; 27(2):161-8. PubMed ID: 7075411
[TBL] [Abstract][Full Text] [Related]
7. Bile acids in bile during long-term chenodeoxycholic acid treatment.
Bremmelgaard A; Pedersen L
Scand J Gastroenterol; 1976; 11(2):161-5. PubMed ID: 1265436
[TBL] [Abstract][Full Text] [Related]
8. 7-Methyl bile acids: effects of chenodeoxycholic acid, cholic acid, and their 7 beta-methyl analogues on the formation of cholesterol gallstones in the prairie dog.
Matoba N; Cohen BI; Mosbach EH; Stenger RJ; Kuroki S; Une M; McSherry CK
Gastroenterology; 1989 Jan; 96(1):178-85. PubMed ID: 2909419
[TBL] [Abstract][Full Text] [Related]
9. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
LaRusso NF; Thistle JL
Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
[TBL] [Abstract][Full Text] [Related]
10. Hepatic morphology and bile acid composition of bile and urine during chenodeoxycholic acid therapy for radiolucent gallstones.
Pedersen L; Bremmelgaard A
Scand J Gastroenterol; 1976; 11(4):385-9. PubMed ID: 935799
[TBL] [Abstract][Full Text] [Related]
11. Portal venous bile acids in cholesterol gallstone disease: effect of treatment with chenodeoxycholic and cholic acids.
Einarsson K; Ahlberg J; Angelin B; Björkhem I; Ewerth S
Hepatology; 1985; 5(4):661-5. PubMed ID: 4018738
[TBL] [Abstract][Full Text] [Related]
12. Hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and biliary lipid composition in man: relation to cholesterol gallstone disease and effects of cholic acid and chenodeoxycholic acid treatment.
Ahlberg J; Angelin B; Einarsson K
J Lipid Res; 1981 Mar; 22(3):410-22. PubMed ID: 7240966
[TBL] [Abstract][Full Text] [Related]
13. Mesophase formation during cholesterol gallstone dissolution in human bile: effect of bile acid composition.
Su CC; Higuchi WI; Gilmore IT; Danzinger RG; Hofmann AF
J Pharm Sci; 1984 Aug; 73(8):1160-1. PubMed ID: 6491925
[TBL] [Abstract][Full Text] [Related]
14. The lack of relationship between hepatotoxicity and lithocholic-acid sulfation in biliary bile acids during chenodiol therapy in the National Cooperative Gallstone Study.
Fisher RL; Hofmann AF; Converse JL; Rossi SS; Lan SP
Hepatology; 1991 Sep; 14(3):454-63. PubMed ID: 1874490
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the effects of an equal dose of 15 mg/kg/day of chenodeoxycholic and ursodeoxycholic acid on the composition of biliary lipids and acids in the bile in radiotransparent biliary lithiasis].
Garrido G; Breto M; Alegre B; Pérez Aguilar F; Berenguer J
Rev Esp Enferm Apar Dig; 1983 Oct; 64(4):261-9. PubMed ID: 6658120
[No Abstract] [Full Text] [Related]
16. Effects of biliary bile acid composition on biliary cholesterol saturation in gallstone patients treated with chenodeoxycholic acid and/or ursodeoxycholic acid.
Stiehl A; Raedsch R; Czygan P; Götz R; Männer C; Walker S; Kommerell B
Gastroenterology; 1980 Dec; 79(6):1192-8. PubMed ID: 7439628
[TBL] [Abstract][Full Text] [Related]
17. Comparative efficacy and side effects of ursodeoxycholic and chenodeoxycholic acids in dissolving gallstones. A double-blind controlled study.
Fromm H; Roat JW; Gonzalez V; Sarva RP; Farivar S
Gastroenterology; 1983 Dec; 85(6):1257-64. PubMed ID: 6354826
[TBL] [Abstract][Full Text] [Related]
18. Semiquantitative measurement of lithocholic acid compounds in bile from patients with gallstones, before and during treatment with chenodeoxycholic acid.
Arnfred T; Pedersen L
Scand J Gastroenterol; 1976; 11(5):497-504. PubMed ID: 959764
[TBL] [Abstract][Full Text] [Related]
19. [Changes in biliary bile acid composition and cholesterol saturation of bile in patients with cholesterol gallstones following treatment with ursodeoxycholic acid].
Stiehl A; Czygan P; Fröhling W; Kommerell B
Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():501-2. PubMed ID: 612017
[No Abstract] [Full Text] [Related]
20. Effect of 7-ketolithocholic acid on bile acid metabolism in humans.
Salen G; Verga D; Batta AK; Tint GS; Shefer S
Gastroenterology; 1982 Aug; 83(2):341-7. PubMed ID: 7084613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
